Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

All

ATC	Name	B/G ↑	Ingredients	Dosage	Form	Price
L01XX24	ONCASPAR	B	Pegaspargase - 750U/ml	750U/ml	Injectable powder for solution	172,758,585 L.L
M05BX	OSSOPAN	B	Osseine-hydroxyapatite complex - 800mg	800mg	Tablet, film coated	1,142,266 L.L
C02KX04	OPSUMIT	B	Macitentan - 10mg	10mg	Tablet, film coated	201,006,231 L.L
A10BJ06	OZEMPIC	B	Semaglutide - 0.25mg	0.25mg	Injectable solution	10,927,526 L.L
A10BJ06	OZEMPIC	B	Semaglutide - 0.5mg	0.5mg	Injectable solution	10,927,526 L.L
A10BJ06	OZEMPIC	B	Semaglutide - 1mg	1mg	Injectable solution	10,927,526 L.L
R01AA07	OTRIVIN	B	Xylometazoline HCl - 0.1%	0.10%	Solution	260,705 L.L
R01AA07	OTRIVIN	B	Xylometazoline HCl - 0.1%	0.10%	Drops	241,892 L.L
R01AA07	OTRIVIN MENTHOL 0.1%	B	Xylometazoline HCl - 0.1%	0.10%	Drops	387,027 L.L
R01AA07	OTRIVIN	B	Xylometazoline HCl - 0.05%	0.05%	Solution	260,705 L.L
R01AA07	OTRIVIN	B	Xylometazoline HCl - 0.05%	0.05%	Drops	181,419 L.L
R01AB06	OTRIVIN DUAL RELIEF	B	Xylometazoline HCl - 0.5mg/ml, Ipratropium bromide - 0.6mg/ml		Solution	563,070 L.L
R01AD08	OTRIALLERGY	B	Fluticasone propionate - 50mcg/actuation	50mcg/actuation	Spray, suspension	675,953 L.L
A11CC03	ONE-ALPHA	B	Alfacalcidol - 2mcg/ml	2mcg/ml	Injectable solution	2,218,684 L.L
A11CC03	ONE-ALPHA	B	Alfacalcidol - 2mcg/ml	2mcg/ml	Injectable solution	4,219,665 L.L
N02AA05	OXYNORM	B	Oxycodone HCl - 5mg	5mg	Capsule, hard	1,991,575 L.L
A11CC03	ONE-ALPHA	B	Alfacalcidol - 1mcg	1mcg	Capsule	3,735,882 L.L
N02AA05	OXYNORM	B	Oxycodone HCl - 10mg	10mg	Capsule, hard	3,988,525 L.L
N02AA05	OXYNORM	B	Oxycodone HCl - 20mg	20mg	Capsule, hard	7,634,958 L.L
A11CC03	ONE-ALPHA	B	Alfacalcidol - 0.25mcg	0.25mcg	Capsule	1,138,235 L.L
N02AA05	OXYNORM	B	Oxycodone HCl - 10mg/ml	10mg/ml	Injectable solution	1,584,390 L.L
A11CC03	ONE-ALPHA	B	Alfacalcidol - 0.5mcg	0.5mcg	Capsule	943,377 L.L
A11CC03	ONE-ALPHA	B	Alfacalcidol - 0.5mcg	0.5mcg	Capsule	942,034 L.L
A11CC03	ONE-ALPHA	B	Alfacalcidol - 2mcg/ml	2mcg/ml	Drops solution	1,343,843 L.L
L01XX24	ONCASPAR	B	Pegaspargase - 750U/ml	750U/ml	Injectable powder for solution	L.L
C09CA08	OLMETEC	B	Olmesartan medoxomil - 10mg	10mg	Tablet, film coated	710,893 L.L
C09CA08	OLMETEC	B	Olmesartan medoxomil - 20mg	20mg	Tablet, film coated	888,280 L.L
C09CA08	OLMETEC	B	Olmesartan medoxomil - 40mg	40mg	Tablet, film coated	920,532 L.L
G04CA02	OMNIC OCAS	B	Tamsulosin HCl - 0.4mg	0.4mg	Tablet, film coated, prolonged release	866,778 L.L
R03AC18	ONBREZ BREEZHALER	B	Indacaterol maleate - 150mcg	150mcg	Capsule, inhalation	2,284,532 L.L

...